Search - tctmd.com

Displaying 81 - 100 of 1832

Sort: Relevancy | Date

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

L.A. McKeown

March 21, 2025

News Daily News

Australia’s Heat-Related Burden of CVD Holds Warnings for All

L.A. McKeown

March 20, 2025

News Daily News

Cannabis Use Again Tied to Increased CVD Risk in Young People

L.A. McKeown

March 19, 2025

News Daily News

AHA Offers Help for Clinicians Weighing the Results of DTC Genetic Tests

Yael L. Maxwell

March 18, 2025

News Daily News

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Michael O'Riordan

March 18, 2025

News Daily News

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Michael O'Riordan

March 13, 2025

News Conference News CRT 2025

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

L.A. McKeown

March 12, 2025

News Daily News

Food Insecurity in Adulthood Signals Greater Risk of Later CVD

Todd Neale

March 12, 2025

News Daily News

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Michael O'Riordan

March 11, 2025

News Daily News

Fasting Not Needed Before Cath Lab Procedures: Meta-analysis

Todd Neale

March 11, 2025

News Daily News

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Michael O'Riordan

March 06, 2025

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

News Daily News

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Michael O'Riordan

March 04, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2025

Shelley Wood

February 28, 2025

News Daily News

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

L.A. McKeown

February 24, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Daily News

AHA Scientific Statement Takes Aim at PAD Pain

L.A. McKeown

February 13, 2025

News Daily News

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Michael O'Riordan

February 12, 2025

Advertisement

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

What’s Going to Be Hot at ACC 2025?

March 2025 Dispatch for the CV Team

Australia’s Heat-Related Burden of CVD Holds Warnings for All

Cannabis Use Again Tied to Increased CVD Risk in Young People

AHA Offers Help for Clinicians Weighing the Results of DTC Genetic Tests

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

Food Insecurity in Adulthood Signals Greater Risk of Later CVD

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Fasting Not Needed Before Cath Lab Procedures: Meta-analysis

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

Coverage and Use of Impella and Watchman: A Tale of Four Countries

TCTMD’s Top 10 Most Popular Stories for February 2025

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

AHA Scientific Statement Takes Aim at PAD Pain

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content